# US 2013/0157876 A1 · Systems and Methods for Detecting Antibiotic Resistance

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157876 A1
- Document ID: US20130157876A1
- Status: Published application
- Kind: A1
- Application number: 13/773,631
- Filed: 2013-02-21
- Published: 2013-06-20
- Earliest claimed: 2010-08-21
- Assignees: Tessarae Inc.; The Regents of the University of California
- Inventors: Susan V. Lynch; Eoin L. Brodie; Ulas Karaoz; Ramya Srinivasan; Anjan Purkayastha; Matthew C. Lorence; Clark J. Tibbetts
- Web page: https://patentgrep.com/patent/US20130157876A1

## CPC

- C12Q 1/689: for bacteria
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6888: for detection or identification of organisms
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A robust, automated computational pipeline was used to design a system comprising a microarray for the identification of microorganisms and their antibiotic resistance profiles. This system and methods will facilitate the study of the epidemiology and microbial ecology of antibiotic resistance and be an invaluable tool to rapidly and simultaneously identify organisms and their antimicrobial resistance elements in environmental, food and clinical samples.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

A method for determining a disease condition of a subject, the method comprising the steps of:
(a) obtaining a sample from a patient;
(b) isolating nucleic acid material from said sample;
(c) amplifying a target locus from said nucleic acid material;
(d) contacting said target locus with a set of probes (resequencing probes), wherein said set comprising 8 probes (4 probes based on the sense strand and 4 probes based on the anti-sense strand) per nucleotide base interrogated in each target locus;
(e) determining hybridization signal strengths across the set of probes;
(f) determining hybridization signal strengths for a plurality of different interrogation probes, each of which is complementary to a section within said target locus;
(g) determining the sequence of the target locus by analysis of the hybridization signal strengths of the resequencing probes;
(h) comparing the target locus sequence with a set of known sequences to determine the presence and/or antibiotic resistance repertoire of one or more target organisms;
(j) defining therapeutic strategy for said patient based on the results of step (h);
(l) classifying, diagnosing, prognosing, and/or predicting an outcome of said condition based on the results of step (h).

### Claim 4

A method for parallel detection and strain level-identification of a panel of more than 44 organisms, in parallel with antibiotic resistance profiling of said organisms comprising the steps of:
a) extraction of nucleic acids from a patient sample using a rapid optimized protocol;
b) amplifying target loci from that sample using multiplex polymerase chain reaction;
c) pooling target locus amplified products;
d) labeling pooled amplified products;
e) contacting the labeled amplified pool of products with a plurality of resequencing probes which target both the sense and anti-sense strands of the target loci represented in SEQ ID NOS:1-1323;
f) determining hybridization signal strength for each of said probes, wherein said determination identifies the specific sequence of the target locus, providing either strain level organism identification in parallel with single nucleotide polymorphism resolution antibiotic resistance determinant sequence information.

### Claim 5

(canceled)

### Claim 6

An array system comprising: a resequencing microarray configured to simultaneously detect a plurality of organisms and antibiotic resistance elements in a sample, wherein the microarray comprises resequencing probes for organism identification, antibiotic resistance element detection, and detection of polymorphisms related to said antibiotic resistance, whereby said resequencing probes for organism detection can provide strain-level detection and identification of a organism in a sample and whereby said resequencing probes for antibiotic resistance elements and said resequencing probes for antibiotic resistance related polymorphisms provide for detection of emerging antibiotic resistance of organisms in a sample.

### Claim 7 (depends on 6)

The array system of claim 6, wherein the plurality of organisms comprise bacteria.

### Claim 8 (depends on 6)

The array system of claim 6, wherein the fragments are about 25 nucleotides long.

### Claim 9 (depends on 6)

The array system of claim 6, wherein the sample is an environmental sample.

### Claim 10 (depends on 9)

The array system of claim 9, wherein the environmental sample comprises at least one of soil, water or atmosphere.

### Claim 11 (depends on 6)

The array system of claim 6, wherein the sample is a clinical sample.

### Claim 12 (depends on 11)

The array system of claim 11, wherein the clinical sample comprises at least one of tissue, skin, stool, bodily fluid or blood.

### Claim 13 (depends on 6)

A method of simultaneously detecting an organism in a sample and its antibiotic resistance comprising the steps: applying a sample comprising a plurality of organisms to the array system of claim 6; and simultaneously identifying at least one organism in the sample and determining its antibiotic resistance.

### Claim 14 (depends on 13)

The method of claim 13, wherein the plurality of organisms comprise bacteria.

### Claim 15 (depends on 13)

The method of claim 13, wherein the fragments are about 25 nucleotides long.

### Claim 16 (depends on 13)

The method of claim 13, wherein the antibiotic resistance elements detected represent new or emerging resistance in the organism or organisms detected in the sample.

### Claim 17

A method of designing and fabricating an array system comprising: identifying organism-specific and antibiotic resistance element sequences corresponding to a plurality of organisms and resistance elements of interest; selecting target loci unique to each organism and resistance element; selecting resequencing probes; and fabricating said array system.

### Claim 18 (depends on 17)

The method of claim 17, wherein the plurality of organisms comprise bacteria.

### Claim 19 (depends on 17)

The method of claim 17, wherein each fragment has a corresponding set of 8 variant fragments per nucleotide base interrogated, 4 based on sense strand and 4 on anti-sense strand.

### Claim 20 (depends on 17)

The method of claim 17, wherein the fragments are about 25 nucleotides long.

### Claim 21

(canceled)

### Claim 22

A computer-readable storage medium comprising a database of antibiotic resistance elements (BARChipDB) comprising 262 bacterial genera/species isolated polynucleotides (SEQ ID NOS:971-1232) and 1,061 isolated polynucleotides comprising resistance determinants sequences (SEQ ID NOS:1-970 and 1233-1323).
